Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 197, pseudogene (RN7SL197P) is a human processed pseudogene derived from the functional 7SL RNA gene, which encodes the RNA component of the signal recognition particle involved in the co-translational targeting of secretory proteins to the endoplasmic reticulum[1][5][7]. As a pseudogene, RN7SL197P does not synthesize a functional product and possesses no recognized biological or disease-related roles. Unlike some active pseudogenes, RN7SL197P does not appear to act as a regulatory non-coding RNA or a ceRNA, nor is it a therapeutic, diagnostic, or prognostic target in any known context[1][4][6].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 197, pseudogene (RN7SL197P).